These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6954762)

  • 1. Analysis of the immunogenetic background of Japanese leprosy patients by the HLA system.
    Izumi S; Sugiyama K; Matsumoto Y; Ohkawa S
    Vox Sang; 1982; 42(5):243-7. PubMed ID: 6954762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculoid leprosy and HLA in Japanese.
    Miyanaga K; Juji T; Maeda H; Nakajima S; Kobayashi S
    Tissue Antigens; 1981 Nov; 18(5):331-4. PubMed ID: 6953616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-linked control of predisposition to lepromatous leprosy.
    van Eden W; Gonzalez NM; de Vries RR; Convit J; van Rood JJ
    J Infect Dis; 1985 Jan; 151(1):9-14. PubMed ID: 3880800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population.
    Ottenhoff TH; Gonzalez NM; de Vries RR; Convit J; van Rood JJ
    Tissue Antigens; 1984 Jul; 24(1):25-9. PubMed ID: 6592792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA and leprosy in Koreans.
    Kim SJ; Choi IH; Dahlberg S; Nisperos B; Kim JD; Hansen JA
    Tissue Antigens; 1987 Mar; 29(3):146-53. PubMed ID: 3603547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan.
    Hiki Y; Kobayashi Y; Itoh I; Kashiwagi N
    Kidney Int; 1984 Jun; 25(6):953-7. PubMed ID: 6332232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HLA system and leprosy in Thailand.
    Greiner J; Schleiermacher E; Smith T; Lenhard V; Vogel F
    Hum Genet; 1978 Jun; 42(2):201-13. PubMed ID: 669704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between human leukocyte antigens and leprosy in the Turkish population.
    Koçak M; Balci M; Pençe B; Kundakçi N
    Clin Exp Dermatol; 2002 May; 27(3):235-9. PubMed ID: 12072016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigens in forms of leprosy among Japanese patients.
    Joko S; Numaga J; Kawashima H; Namisato M; Maeda H
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):49-56. PubMed ID: 10834069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of leprosy with HLA-DR2 in a Southern Brazilian population.
    Visentainer JE; Tsuneto LT; Serra MF; Peixoto PR; Petzl-Erler ML
    Braz J Med Biol Res; 1997 Jan; 30(1):51-9. PubMed ID: 9222403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leprosy associated with HLA-DR2 and DQw1 in the population of northern Thailand.
    Schauf V; Ryan S; Scollard D; Jonasson O; Brown A; Nelson K; Smith T; Vithayasai V
    Tissue Antigens; 1985 Oct; 26(4):243-7. PubMed ID: 3878012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong association of idiopathic membranous nephropathy with HLA-DR2 and MT1 in Japanese.
    Tomura S; Kashiwabara H; Tuchida H; Shishido H; Sakurai S; Miyajima T; Tsuji K; Takeuchi J
    Nephron; 1984; 36(4):242-5. PubMed ID: 6424039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR-associated genetic control of the type of leprosy in a population from surinam.
    van Eden W; de Vries RR; D'Amaro J; Schreuder I; Leiker DL; van Rood JJ
    Hum Immunol; 1982 Jul; 4(4):343-50. PubMed ID: 6811517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA and sporadic tuberculoid leprosy: a population study in Maharashtra, India.
    van Eden W; Mehra NK; Vaidya MC; D'Amaro J; Schreuder GM; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):189-94. PubMed ID: 7336423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker.
    van Eden W; de Vries RR; Mehra NK; Vaidya MC; D'Amaro J; van Rood JJ
    J Infect Dis; 1980 Jun; 141(6):693-701. PubMed ID: 6156220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on the HLA system in leprosy].
    Baranov IuN; Loginov VK
    Vestn Dermatol Venerol; 1988; (8):30-4. PubMed ID: 3057760
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of the HLA class II frequency alleles in patients with leprosy from the mid-west of Brazil.
    Lavado-Valenzuela R; José Bravo M; Junqueira-Kipnis AP; Ramos de Souza M; Moreno C; Alonso A; Liberman-Kipnis T; da Silva WD; Caballero A
    Int J Immunogenet; 2011 Jun; 38(3):255-8. PubMed ID: 21599852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types.
    de Vries RR; Mehra NK; Vaidya MC; Gupte MD; Meera Khan P; Van Rood JJ
    Tissue Antigens; 1980 Oct; 16(4):294-304. PubMed ID: 7008255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA and mycobacterial infection: increased frequency of B8 in Japanese leprosy.
    Takata H; Sada M; Ozawa S; Sekiguchi S
    Tissue Antigens; 1978 Jan; 11(1):61-4. PubMed ID: 75590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA association of lepromatous leprosy and borderline lepromatous leprosy in Turkey. A preliminary study.
    Cem Mat M; Yazici H; Ozbakir F; Tüzün Y
    Int J Dermatol; 1988 May; 27(4):246-7. PubMed ID: 3391713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.